Search results
Results From The WOW.Com Content Network
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.
He also joined Lilly's Board of Directors at that time. Lechleiter was elected as Lilly’s president and chief executive officer (CEO), effective April 1, 2008. Effective January 1, 2009, Lechleiter was appointed as Chairman of the Board of Directors of Eli Lilly and Company, succeeding Sidney Taurel.
Aon Hewitt (formerly known as Hewitt Associates) was a provider of human capital and management consulting services headquartered in Lincolnshire, Illinois in the United States. From 500 offices in 120 countries, it provided consulting, outsourcing, and reinsurance brokerage services. The "Aon Hewitt" brand and legal entities have now been ...
Updated January 4, 2024 at 12:47 PM. Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss drug prescription through a telehealth provider — a ...
Eli Lilly raised both ends of its 2024 revenue forecast by $2 billion and now expects $42.4 billion to $43.6 billion for the year. The drugmaker also raised its annual profit forecast by $1.30 per ...
By Divya Chowdhury and Patrick Wingrove. DAVOS, Switzerland (Reuters) -Eli Lilly on Tuesday said it plans to launch its weight-loss drug Mounjaro in new countries this year as it expands ...
Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out poor manufacturing practices and data falsification involving ...
United Therapeutics. United Therapeutics Corporation is an American publicly traded biotechnology company [2] and public benefit corporation [3] listed on the NASDAQ under the symbol UTHR. [4] [5] It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.